COMMUNIQUÉS West-GlobeNewswire

Canadian Tech Company B-Temia Enters Into a $6.9M USD US Army / Lockheed Martin Agreement
29/11/2018
B-Temia and Lockheed Martin Team Up to Optimize ONYX™ Exoskeleton QUÉBEC CITY, Nov. 29, 2018 (GLOBE NEWSWIRE) -- B-Temia, a Canadian robotics tech company and leader in the human mobility market, announced its [...]
B-Temia, une société canadienne de technologie conclut une entente de 6,9 millions $ US avec l’armée américaine / Lockheed Martin
29/11/2018
B-Temia et Lockheed Martin font équipe en vue d’optimiser l’exosquelette ONYX™ QUÉBEC, 29 nov. 2018 (GLOBE NEWSWIRE) -- B-Temia, une société de technologie robotique canadienne à la tête du marché de la mobilité humaine [...]
Constellation Pharmaceuticals Appoints Patrick Trojer, Ph.D., as Chief Scientific Officer
29/11/2018
CAMBRIDGE, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (the “Company”) (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and [...]
Rafael Pharmaceuticals Announces Initiation of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613 (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
29/11/2018
500 patients will be evaluated in this study at approximately 87 sites in 12 countries. The interim analysis is expected to be completed as early as Q1 2020. Newark, NJ, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Rafael [...]
On “Grindeks” results in the first nine months of 2018
29/11/2018
Turnover of “Grindeks” reaches 102.4 million euro in the first nine months of 2018; profit – 7.6 million euro Today, on 29 November, the JSC “Grindeks” submitted the non-audited consolidated financial statements for the [...]
AREV Builds an Industry-Leading Cannabis Topicals Portfolio-- CFN Media
29/11/2018
SEATTLE, Nov. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Elements Behavioral Health Announces Adoption of Deep Transcranial Magnetic Stimulation (Deep TMS) for Depression in Tennessee Facility
29/11/2018
The company is partnering with HPR Treatment Centers to introduce Deep TMS across multiple locations NUNNELLY, Tenn., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Elements Behavioral Health , the owner of behavioral health [...]
Canntab Nears Commercialization with Innovative Cannabis Tablets-- CFN Media
29/11/2018
SEATTLE, Nov. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
FDA Advisory Committee to Review Investigational Sotagliflozin as Potential Treatment for Type 1 Diabetes
29/11/2018
Endocrinologic and Metabolic Drugs Advisory Committee Meeting Set for January 17, 2019 THE WOODLANDS, Texas, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that the U.S. [...]
As Waking Up Multiple Times a Night to Urinate Can Lead to Memory Deficits, Obesity, Lowered Sex Drive, Falls and Depression, a New Council Urges Awareness and Action
29/11/2018
Advocacy and Industry Form Nocturia Council to Sound the Alarm That Waking Up Multiple Times at Night to Urinate, a Treatable Medical Condition Called Nocturia, Is Causing Distressing Health Issues WASHINGTON, Nov. 29, [...]
CEO Ronan O’Caoimh Increases Shareholding in Trinity Biotech
29/11/2018
DUBLIN, Ireland, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), today announced that Ronan O’Caoimh, CEO of Trinity Biotech, has increased his shareholding in Trinity Biotech by the acquisition of [...]
Abeona Therapeutics to Host R&D Day on December 6, 2018
29/11/2018
NEW YORK and CLEVELAND, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
OraSure Technologies to Ring NASDAQ Stock Market Opening Bell in Honor of World AIDS Day
29/11/2018
OraSure Working to End AIDS on a Global Scale BETHLEHEM, Pa., Nov. 29, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, [...]
Histogenics and FDA Continue to Discuss NeoCart® Phase 3 Clinical Trial Data and Potential Regulatory Pathway
29/11/2018
WALTHAM, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]
Clinical Genomics partners with the Colorectal Cancer Alliance in the Life After Cancer Mission
29/11/2018
BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced its partnership with the Colorectal Cancer [...]
VistaGen Therapeutics Receives Hong Kong Patent for Methods of Production for AV-101
29/11/2018
New Hong Kong patent complements counterpart patents previously issued in China, Europe and the U.S. SOUTH SAN FRANCISCO, Calif., Nov. 29, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage [...]
Todos Medical to Present Scientific Abstract at the Upcoming San Antonio Breast Cancer Symposium (SABCS)
29/11/2018
REHOVOT, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer, announced [...]
Viveve to Host Stress Urinary Incontinence Symposium with Physician Opinion Leaders
29/11/2018
Twelve-month data from the SUI feasibility study to be presented ENGLEWOOD, Colo., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, [...]
Spring Bank Announces Additional Pre-Clinical Data on Its Second-Generation STING Agonist Program at the AACR Special Conference on Tumor Immunology and Immunotherapy
29/11/2018
HOPKINTON, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]

Pages